The cancer burden in Kenya poses a significant risk to our healthcare system. Yet, even as the government increases it’s spending in cancer care and management, there is limited investment in cancer research in the country, especially molecular cancer research. This symposium will illuminate the status and impact of cancer research in Kenya, fostering dialogue between clinicians, researchers, patients, industry players, cancer advocacy groups, and funding agencies. Our goal is to stimulate discussions and collaborations between these stakeholders to spur and drive innovative thinking to drive groundbreaking research in the prevention, diagnosis, and treatment of cancer. 

Our target audience for this symposium include clinical and non-clinical students, academics, research scientists, oncologists, molecular pathologists, healthcare professionals, patient advocates, data scientists, public health professionals, government agencies, biotech and pharmaceutical companies.